India
· Delayed Price · Currency is INR Dr. Lal PathLabs Statistics
Total Valuation
Dr. Lal PathLabs has a market cap or net worth of INR 245.47 billion. The enterprise value is 236.52 billion.
| Market Cap | 245.47B |
| Enterprise Value | 236.52B |
Important Dates
The next estimated earnings date is Wednesday, January 22, 2025.
| Earnings Date | Jan 22, 2025 |
| Ex-Dividend Date | Nov 5, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.05% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 36.98M |
Valuation Ratios
The trailing PE ratio is 61.15.
| PE Ratio | 61.15 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 20.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.20, with an EV/FCF ratio of 47.31.
| EV / Earnings | 58.92 |
| EV / Sales | 10.08 |
| EV / EBITDA | 36.20 |
| EV / EBIT | 45.69 |
| EV / FCF | 47.31 |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.87 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.40 |
| Interest Coverage | 20.25 |
Financial Efficiency
Return on equity (ROE) is 21.17% and return on invested capital (ROIC) is 14.91%.
| Return on Equity (ROE) | 21.17% |
| Return on Assets (ROA) | 12.83% |
| Return on Capital (ROIC) | 14.91% |
| Revenue Per Employee | 5.72M |
| Profits Per Employee | 979,349 |
| Employee Count | 4,099 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 22.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.51% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.51% |
| 50-Day Moving Average | 3,109.05 |
| 200-Day Moving Average | 2,871.25 |
| Relative Strength Index (RSI) | 40.21 |
| Average Volume (20 Days) | 3,249 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Lal PathLabs had revenue of INR 23.46 billion and earned 4.01 billion in profits. Earnings per share was 46.41.
| Revenue | 23.46B |
| Gross Profit | 13.57B |
| Operating Income | 5.18B |
| Pretax Income | 5.69B |
| Net Income | 4.01B |
| EBITDA | 6.16B |
| EBIT | 5.18B |
| Earnings Per Share (EPS) | 46.41 |
Balance Sheet
The company has 11.27 billion in cash and 1.99 billion in debt, giving a net cash position of 9.28 billion.
| Cash & Cash Equivalents | 11.27B |
| Total Debt | 1.99B |
| Net Cash | 9.28B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.35B |
| Book Value Per Share | 240.44 |
| Working Capital | 8.63B |
Cash Flow
In the last 12 months, operating cash flow was 5.37 billion and capital expenditures -365.67 million, giving a free cash flow of 5.00 billion.
| Operating Cash Flow | 5.37B |
| Capital Expenditures | -365.67M |
| Free Cash Flow | 5.00B |
| FCF Per Share | n/a |
Margins
Gross margin is 57.84%, with operating and profit margins of 22.06% and 17.11%.
| Gross Margin | 57.84% |
| Operating Margin | 22.06% |
| Pretax Margin | 24.24% |
| Profit Margin | 17.11% |
| EBITDA Margin | 26.24% |
| EBIT Margin | 22.06% |
| FCF Margin | 21.31% |
Dividends & Yields
This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 30.00 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 50.69% |
| Buyback Yield | -4.05% |
| Shareholder Yield | -3.05% |
| Earnings Yield | 1.57% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |